
KRM Ayurveda Limited, established in 2019, operates a network of six hospitals and five clinics across India, specializing in authentic Ayurvedic treatments for chronic and lifestyle-related health issues such as kidney disorders, liver cirrhosis, and diabetes. The company integrates traditional Ayurvedic practices with modern healthcare approaches, offering personalized care through in-patient, out-patient, and telemedicine services. KRM Ayurveda also has a global reach through its tele-consultancy services and operates its own GMP-certified medicine processing unit to ensure the quality of its Ayurvedic products.
Jan 21, 2026
Jan 23, 2026
Jan 29, 2026
SME
Closed
77 Cr
77 Cr
0 Cr
₹128 - ₹135
1000
Our Company intends to utilize the Net Proceeds for the following objects:
Capital Expenditure for Construction and Development of Telemedicine Operational Facilities: To deploy approximately ₹1366.68 Lakhs for the construction of a new multi-storey office building to unify corporate functions, expand telemedicine operations, save on rent, and enhance operational efficiency.
Purchase of CRM Software and Hardware Infrastructure: To utilize approximately ₹141.55 Lakhs for acquiring CRM software to centralize patient data and improve engagement, along with 130 desktop computers and 25 printers to upgrade IT infrastructure.
Human Resources: To allocate ₹543.82 Lakhs for hiring approximately 80 new professionals, including doctors, nurses, and therapists, to strengthen clinical capacity and support the expansion of hospital and clinic operations.
Repayment/Prepayment of loan: To use up to ₹1,250.00 Lakhs for the full or partial repayment/prepayment of existing borrowings, which will help reduce outstanding debt, lower interest costs, and improve the debt-to-equity ratio.
To meet out the Working Capital requirements of the Company: To allocate ₹1,800.00 Lakhs to fund the company's growing working capital needs, driven by business expansion and the shift towards the services sector.
To meet out the General Corporate Purposes.
17.32
7.79
21.84%
21.84%
21.84%
—
16.83%
26.54%
5.27
Skilled Ayurvedic physicians and certified therapists ensuring treatment quality.
Centralized GMP-certified production of Ayurvedic medicines ensuring purity and efficacy.
Trusted brand with loyal customer base and repeat clientele.
Operational complexity managing consistent quality across diverse locations.
Dependence on availability of quality herbs and raw materials.
Limited brand awareness in some newly targeted regions.
Growing consumer shift towards natural and preventive healthcare solutions.
Increasing domestic and international medical tourism in Ayurveda.
Development of digital health and telemedicine services to reach remote patients.
Launch of proprietary Ayurvedic wellness products for retail and export markets.
Competition from both modern healthcare providers and other Ayurveda chains.
Regulatory changes and compliance requirements in multiple states.
Economic fluctuations impacting patient affordability.
Risk of misinformation impacting Ayurveda's perception among consumers.
KRM Ayurveda Limited, established in 2019, operates a network of six hospitals and five clinics across India, specializing in authentic Ayurvedic treatments for chronic and lifestyle-related health issues such as kidney disorders, liver cirrhosis, and diabetes. The company integrates traditional Ayurvedic practices with modern healthcare approaches, offering personalized care through in-patient, out-patient, and telemedicine services. KRM Ayurveda also has a global reach through its tele-consultancy services and operates its own GMP-certified medicine processing unit to ensure the quality of its Ayurvedic products.
The KRM Ayurveda Ltd. IPO is scheduled to open for subscription on Jan 21, 2026 and close on Jan 23, 2026. Investors can apply for shares during this period through eligible platforms.
The price band for the KRM Ayurveda Ltd. IPO is ₹128 to ₹135. Investors can place bids within this range once the issue opens.
The minimum lot size for the KRM Ayurveda Ltd. IPO is 1000 shares. The minimum investment amount ₹1,35,000.
The total issue size of the KRM Ayurveda Ltd. IPO is approximately ₹77.00. Issue size represents the total value of shares offered to the public.
As per the latest available information, the KRM Ayurveda Ltd. IPO has been subscribed 2.8 times. Subscription levels can change significantly during the offer period.
The Grey Market Premium (GMP) for the KRM Ayurveda Ltd. IPO is not available as of now. GMP reflects unofficial market sentiment and should not be considered a guarantee of listing performance.
The shares of KRM Ayurveda Ltd. are expected to list on stock exchanges on Jan 29, 2026, subject to completion of the allotment process and regulatory approvals.
The net proceeds from the KRM Ayurveda Ltd. IPO are proposed to be used for Our Company intends to utilize the Net Proceeds for the following objects:, Capital Expenditure for Construction and Development of Telemedicine Operational Facilities: To deploy approximately ₹1366.68 Lakhs for the construction of a new multi-storey office building to unify corporate functions, expand telemedicine operations, save on rent, and enhance operational efficiency., Purchase of CRM Software and Hardware Infrastructure: To utilize approximately ₹141.55 Lakhs for acquiring CRM software to centralize patient data and improve engagement, along with 130 desktop computers and 25 printers to upgrade IT infrastructure., Human Resources: To allocate ₹543.82 Lakhs for hiring approximately 80 new professionals, including doctors, nurses, and therapists, to strengthen clinical capacity and support the expansion of hospital and clinic operations., Repayment/Prepayment of loan: To use up to ₹1,250.00 Lakhs for the full or partial repayment/prepayment of existing borrowings, which will help reduce outstanding debt, lower interest costs, and improve the debt-to-equity ratio., To meet out the Working Capital requirements of the Company: To allocate ₹1,800.00 Lakhs to fund the company's growing working capital needs, driven by business expansion and the shift towards the services sector., To meet out the General Corporate Purposes.
Before applying for the KRM Ayurveda Ltd. IPO, investors generally review the company’s business model, financial performance, valuation, industry outlook, and risk factors mentioned in the offer document.